A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer
Status:
NOT_YET_RECRUITING
Trial end date:
2031-10-01
Target enrollment:
Participant gender:
Summary
To find out if the combination of BMS-986504 plus neoadjuvant/adjuvant chemotherapy and surgery (Cohort 1) or BMS-986504 plus standard of care chemotherapy (Cohorts 2 and 3) can help to control pancreatic cancer.